Schidigerasaponin B1



Compound IDCDAMM02816
Common nameSchidigerasaponin B1
IUPAC name16-[5-hydroxy-6-(hydroxymethyl)-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-(3,4,5-trihydroxyoxan-2-yl)oxyoxan-2-yl]oxy-7,9,13-trimethyl-5\'-methylidenespiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2\'-oxane]-10-one
Molecular formulaC44H68O18

Experimental data

Retention time23.91
Adduct[M+Na]+
Actual mz907.434
Theoretical mz907.43
Error4.39
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score5.7801

Identifiers and class information

Inchi keyCIJLYOWWFYEYAN-UHFFFAOYNA-N
SmilesO=C1CC2C(CCC3CC(OC4OC(CO)C(O)C(OC5OCC(O)C(O)C5O)C4OC6OC(CO)C(O)C(O)C6O)CCC32C)C7CC8OC9(OCC(=C)CC9)C(C)C8C17C
SuperclassLipids and lipid-like molecules
ClassSteroids and steroid derivatives

Pharmacokinetic properties

Number of descriptor values(#stars)13
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)17
Number of reactive functional groups (#rtvFG)4
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)885.01
Computed dipole moment(dipole)5.345
Total solvent accessible surface area (SASA)1138.97
Hydrophobic component of SASA (FOSA)803.976
Hydrophilic component of SASA (FISA)299.142
Pie component of the SASA (PISA)35.855
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)2388.62
Number of hydrogen bond donors (donorHB)9
Number of hydrogen bond acceptors (accptHB)29
Free energy of solvation of dipole (dip^2/V)0.0119601
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0763846
Globularity descriptor (glob)0.758723
Predicted polarizability in cubic angstroms (QPpolrz)78.865
Predicted hexadecane/gas partition coefficient (QPlogPC16)24.558
Predicted octanol/gas partition coefficient (QPlogPoct)55.978
Predicted water/gas partition coefficient (QPlogPw)42.735
Predicted octanol/water partition coefficient (QPlogPo/w)-0.584
Predicted aqueous solubility (QPlogS)-3.87
Conformation-independent predicted aqueous solubility (CIQPlogS)-5.219
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-5.607
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)14.426
Predicted brain/blood partition coefficient (QPlogBB)-3.925
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)5.065
Predicted skin permeability, log Kp (QPlogKp)-5.274
PM3 calculated ionization potential (IP(ev))9.987
PM3 calculated electron affinity (EA(eV))-0.622
Number of likely metabolic reactions (#metab)12
Prediction of binding to human serum albumin (QPlogKhsa)-1.277
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)5.399
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)267.994
Number of nitrogen and oxygen atoms (#NandO)18
Number of violations of Lipinski’s rule of five (RuleOfFive)3
Number of violations of Jorgensen’s rule of three (RuleOfThree)2

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P05230FGF1Acidic fibroblast growth factorT18639SEA
P05023ATP1A1Sodium/potassium-transporting ATPase alpha-1 chainT40800SEA
P60568IL2Interleukin-2T61698SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T18639DI0081Chronic arterial occlusive disease[ICD-11: BD4Z]P05230FGF1
T18639DI0102Coronary atherosclerosis[ICD-11: BA52]P05230FGF1
T40800DI0068Cardiac arrhythmia[ICD-11: BC9Z]P05023ATP1A1
T40800DI0086Chronic obstructive pulmonary disease[ICD-11: CA22]P05023ATP1A1
T40800DI0101Corneal disease[ICD-11: 9A76-9A78]P05023ATP1A1
T40800DI0175Heart failure[ICD-11: BD10-BD1Z]P05023ATP1A1
T40800DI0186Hyperhidrosis[ICD-11: EE00]P05023ATP1A1
T40800DI0243Malaria[ICD-11: 1F40-1F45]P05023ATP1A1
T40800DI0397Supraventricular tachyarrhythmia[ICD-11: BC81]P05023ATP1A1
T61698DI0275Multiple sclerosis[ICD-11: 8A40]P60568IL2
T61698DI0361Renal cell carcinoma[ICD-11: 2C90]P60568IL2

Copyright © 2025